Resistance to type II JAK2 inhibition in MPN is dependent on chromatin remodeling and MAPK activation and is targetable Meeting Abstract
| Authors: | Szybinski, J.; Codilupi, T.; Stivala, S.; Brkic, S.; Yang, J. L.; Wicki, A.; Ghosh, N.; Passweg, J.; Dirnhofer, S.; Levine, R. L.; Koche, R.; Meyer, S. C. |
| Abstract Title: | Resistance to type II JAK2 inhibition in MPN is dependent on chromatin remodeling and MAPK activation and is targetable |
| Meeting Title: | Swiss Oncology and Hematology Congress (SOHC) |
| Journal Title: | Swiss Medical Weekly |
| Volume: | 151 |
| Meeting Dates: | 2021 Nov 18-20 |
| Meeting Location: | Zürich, Switzerland |
| ISSN: | 1424-7860 |
| Publisher: | E M H Swiss Medical Publishers Ltd |
| Date Published: | 2021-11-17 |
| Start Page: | w30107 |
| Language: | English |
| ACCESSION: | WOS:000760549700019 |
| PROVIDER: | wos |
| PUBMED: | 34846116 |
| DOI: | 10.4414/smw.2021.w30107 |
| Notes: | Meeting Abstract: O18 -- Located on page 12S of the publication -- Supplementum 255 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
